A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo
Nataly Tarasenko, Suzanne M. Cutts, Don R. Phillips, Gili Berkovitch-Luria, Elinor Bardugo-Nissim, Michal Weitman, Abraham Nudelman, Ada Rephaeli
Research output: Contribution to journal › Article › peer-review
18Scopus
citations
Fingerprint
Dive into the research topics of 'A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo'. Together they form a unique fingerprint.